tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Manish Somaiya, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst Manish Somaiya, currently employed carries an average stock price target met ratio of 58.33% that have a potential upside of 56.36% achieved within 284 days. Previously, Manish Somaiya worked at BMO, NOMURA.
Manish Somaiya’s has documented 26 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PTGX, Protagonist Therapeutics at 27-Mar-2018.
Analyst best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 9/6/2016. The price target of $21 was fulfilled within 24 days with a profit of $8.46 (67.46%) receiving and performance score of 28.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$50
$8.89 (21.62%)
$50
10 days ago
(11-Nov-2024)
17/22 (77.27%)
$2.73 (5.78%)
264
Buy
$43
$1.89 (4.60%)
$45
3 months 14 days ago
(07-Aug-2024)
9/9 (100%)
$7.21 (20.15%)
185
Buy
$48
$6.89 (16.76%)
$37
3 months 27 days ago
(25-Jul-2024)
3/3 (100%)
$6.43 (15.47%)
163
Buy
$51
$9.89 (24.06%)
$41
3 months 28 days ago
(24-Jul-2024)
2/4 (50%)
$9.11 (21.75%)
629
Buy
$35
$-6.11 (-14.86%)
$35
1 years 4 months 18 days ago
(03-Jul-2023)
3/10 (30%)
$12.69 (56.88%)
557
What Year was the first public recommendation made by Manish Somaiya?
